Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312822200 on January 26, 2004

J. Biol. Chem., Vol. 279, Issue 15, 14531-14541, April 9, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/15/14531    most recent
M312822200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsukiyama-Kohara, K.
Right arrow Articles by Kohara, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsukiyama-Kohara, K.
Right arrow Articles by Kohara, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Activation of the CKI-CDK-Rb-E2F Pathway in Full Genome Hepatitis C Virus-expressing Cells*

Kyoko Tsukiyama-Kohara,ab Shigenobu Toné,ac Isao Maruyama,a Kazuaki Inoue,ad Asao Katsume,ae Hideko Nuriya,a Hiroshi Ohmori,e Jun Ohkawa,f Kazunari Taira,g Yutaka Hoshikawa,h Futoshi Shibasaki,h Michael Reth,i Yohsuke Minatogawa,c and Michinori Koharaaj

From the Departments of aMicrobiology and Cell Biology and hCell Physiology, Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613, Japan, the cDepartment of Biochemistry, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan, the dDivision of Gastroenterology, Showa University Fujigaoka Hospital, Aoba-ku, Fujigaoka 1-30, Yokohama 227-8501, Japan, the eFuji Gotemba Research Laboratory, Chugai Pharmaceutical Company, Limited, 135 Komakado 1-chome, Gotemba-shi, Shizuoka 412, Japan, the fAIDS Research Center, National Institute of Health, 1-23-1 Toyama-cho, Shinjuku-ku, Tokyo 162-8640, Japan, the gDepartment of Chemistry and Biotechnology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan, and the iMax-Planck-Institut für Immunbiologie, Stubeweg 51, D-79108 Freiburg, Germany

Hepatitis C virus (HCV) causes persistent infection in hepatocytes, and this infection is, in turn, strongly associated with the development of hepatocellular carcinoma. To clarify the mechanisms underlying these effects, we established a Cre/loxP conditional expression system for the precisely self-trimmed HCV genome in human liver cells. Passage of hepatocytes expressing replicable full-length HCV (HCR6-Rz) RNA caused up-regulation of anchorage-independent growth after 44 days. In contrast, hepatocytes expressing HCV structural, nonstructural, or all viral proteins showed no significant changes after passage for 44 days. Only cells expressing HCR6-Rz passaged for 44 days displayed acceleration of CDK activity, hyperphosphorylation of Rb, and E2F activation. These results demonstrate that full genome HCV expression up-regulates the CDK-Rb-E2F pathway much more effectively than HCV proteins during passage.


Received for publication, November 24, 2003 , and in revised form, January 12, 2004.

* This work was supported by grant-in-aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Ministry of Health, Labor, and Welfare of Japan and by the Organization for Pharmaceutical Safety and Research of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b Present address: Lab. Animal Research Center, Inst. of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.

j To whom correspondence should be addressed. Tel.: 81-3-3823-2101; Fax: 81-3-3828-8945; E-mail: mkohara{at}rinshoken.or.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. Dominguez-Villar, A. Munoz-Suano, B. Anaya-Baz, S. Aguilar, J. P. Novalbos, J. A. Giron, M. Rodriguez-Iglesias, and F. Garcia-Cozar
Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis
J. Leukoc. Biol., November 1, 2007; 82(5): 1301 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Munakata, M. Nakamura, Y. Liang, K. Li, and S. M. Lemon
Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase
PNAS, December 13, 2005; 102(50): 18159 - 18164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. P. Claudio, G. Russo, C. A. C. Y. Kumar, C. Minimo, A. Farina, S. Tutton, G. Nuzzo, F. Giuliante, G. Angeloni, V. Maria, et al.
pRb2/p130, Vascular Endothelial Growth Factor, p27(KIP1), and Proliferating Cell Nuclear Antigen Expression in Hepatocellular Carcinoma: Their Clinical Significance
Clin. Cancer Res., May 15, 2004; 10(10): 3509 - 3517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement